Esthesioneuroblastoma: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
(Mahshid) |
||
| (10 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Esthesioneuroblastoma}} | {{Esthesioneuroblastoma}} | ||
{{CMG}} | {{CMG}}{{AE}}{{Simrat}} | ||
{{SK}} | {{SK}} Olfactory neuroblastoma; Aesthesioneuroblastoma | ||
==[[Esthesioneuroblastoma overview|Overview]]== | ==[[Esthesioneuroblastoma overview|Overview]]== | ||
| Line 34: | Line 20: | ||
==[[Esthesioneuroblastoma risk factors|Risk Factors]]== | ==[[Esthesioneuroblastoma risk factors|Risk Factors]]== | ||
==[[Esthesioneuroblastoma screening|Screening]]== | |||
==[[Esthesioneuroblastoma natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | ==[[Esthesioneuroblastoma natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | ||
==Diagnosis== | ==Diagnosis== | ||
[[Esthesioneuroblastoma history and symptoms| History and Symptoms]] | [[Esthesioneuroblastoma physical examination | Physical Examination]] | [[Esthesioneuroblastoma laboratory findings|Laboratory Findings]] | [[Esthesioneuroblastoma CT|CT]] | [[Esthesioneuroblastoma MRI|MRI | [[Esthesioneuroblastoma staging| Staging]] | [[Esthesioneuroblastoma history and symptoms| History and Symptoms]] | [[Esthesioneuroblastoma physical examination | Physical Examination]] | [[Esthesioneuroblastoma laboratory findings|Laboratory Findings]] | [[Esthesioneuroblastoma CT|CT]] | [[Esthesioneuroblastoma MRI|MRI]] | [[Esthesioneuroblastoma other imaging findings|Other Imaging Findings]] | [[Esthesioneuroblastoma other diagnostic studies|Other Diagnostic Studies]] | ||
==Treatment== | ==Treatment== | ||
[[Esthesioneuroblastoma medical therapy|Medical Therapy]] | [[Esthesioneuroblastoma surgery|Surgery]] | [[Esthesioneuroblastoma primary prevention|Primary Prevention]] | [[Esthesioneuroblastoma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Esthesioneuroblastoma future or investigational therapies|Future or Investigational Therapies]] | [[Esthesioneuroblastoma medical therapy|Medical Therapy]] | [[Esthesioneuroblastoma surgery|Surgery]] | [[Esthesioneuroblastoma primary prevention|Primary Prevention]] | [[Esthesioneuroblastoma secondary prevention|Secondary Prevention]] | [[Esthesioneuroblastoma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Esthesioneuroblastoma future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | ==Case Studies== | ||
[[Esthesioneuroblastoma case study one|Case#1]] | [[Esthesioneuroblastoma case study one|Case#1]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[Category: | [[Category:Neurology]] | ||
[[Category:Rhinology]] | [[Category:Rhinology]] | ||
| Line 60: | Line 43: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Neurology]] | |||
[[Category:Neurosurgery]] | |||
Latest revision as of 22:22, 26 November 2017
|
Esthesioneuroblastoma Microchapters | |
|
Diagnosis | |
|---|---|
|
Treatment | |
|
Case Studies | |
|
Esthesioneuroblastoma On the Web | |
|
American Roentgen Ray Society Images of Esthesioneuroblastoma | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]
Synonyms and keywords: Olfactory neuroblastoma; Aesthesioneuroblastoma
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Esthesioneuroblastoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging | History and Symptoms | Physical Examination | Laboratory Findings | CT | MRI | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies